Xu Deng

728 total citations
23 papers, 478 citations indexed

About

Xu Deng is a scholar working on Cancer Research, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Xu Deng has authored 23 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 4 papers in Pathology and Forensic Medicine and 3 papers in Molecular Biology. Recurrent topics in Xu Deng's work include Breast Lesions and Carcinomas (4 papers), Breast Cancer Treatment Studies (3 papers) and Air Quality and Health Impacts (2 papers). Xu Deng is often cited by papers focused on Breast Lesions and Carcinomas (4 papers), Breast Cancer Treatment Studies (3 papers) and Air Quality and Health Impacts (2 papers). Xu Deng collaborates with scholars based in China, United States and Japan. Xu Deng's co-authors include Wenyan Li, Qin Liu, Yiwen Chen, Shudan Liu, Mary Story, Jigang Dai, Truls Østbye, Xin Huang, Bo Yang and Quanxing Liu and has published in prestigious journals such as ACS Nano, The Science of The Total Environment and Molecules.

In The Last Decade

Xu Deng

19 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu Deng China 11 130 113 106 81 66 23 478
Fariba Salehi Canada 10 125 1.0× 56 0.5× 76 0.7× 99 1.2× 44 0.7× 17 472
Heng‐Gui Chen China 14 97 0.7× 42 0.4× 150 1.4× 174 2.1× 57 0.9× 30 618
Hongguang Zhang China 13 81 0.6× 153 1.4× 49 0.5× 31 0.4× 73 1.1× 35 439
Athanasios Zachariou Greece 16 209 1.6× 93 0.8× 328 3.1× 81 1.0× 111 1.7× 83 761
Mandy Goldberg United States 9 54 0.4× 65 0.6× 54 0.5× 85 1.0× 47 0.7× 32 336
Carla Di Dato Italy 11 122 0.9× 94 0.8× 187 1.8× 37 0.5× 73 1.1× 13 573
Marcin Jóźwik Poland 18 212 1.6× 228 2.0× 191 1.8× 19 0.2× 124 1.9× 76 1.0k
Shio-Jean Lin Taiwan 18 120 0.9× 176 1.6× 71 0.7× 60 0.7× 199 3.0× 43 789
Ashley Pajak United States 12 90 0.7× 83 0.7× 76 0.7× 401 5.0× 40 0.6× 15 720
Dorota Raczkiewicz Poland 14 127 1.0× 67 0.6× 136 1.3× 20 0.2× 67 1.0× 90 681

Countries citing papers authored by Xu Deng

Since Specialization
Citations

This map shows the geographic impact of Xu Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Deng more than expected).

Fields of papers citing papers by Xu Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Deng. The network helps show where Xu Deng may publish in the future.

Co-authorship network of co-authors of Xu Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Deng. A scholar is included among the top collaborators of Xu Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Deng. Xu Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Ting, et al.. (2025). Malignant phyllodes tumors with sarcomatous components: A histopathologic and molecular study. Translational Oncology. 53. 102318–102318.
2.
Wang, Mei, et al.. (2025). Antiviral strategies based on targeted protein degradation: An overview of the literature and future outlook. European Journal of Medicinal Chemistry. 301. 118208–118208.
3.
Zhou, Xing, Wan Chen, Xu Deng, et al.. (2025). Hybrid Exosome–Liposome Nanoparticles for Dual Modulation of Neuroinflammation and Lipid Metabolism in Ischemic Stroke. ACS Nano. 19(37). 33567–33586.
4.
Chen, Ling, Tiao Luo, Jijia Li, et al.. (2024). Synthesis and biological evaluation of novel isoxazoloquinone derivatives as potent STAT3-targeting antipsoriasis agents. Bioorganic Chemistry. 151. 107617–107617.
6.
Lei, Ting, et al.. (2022). The genomic profile of double primary secretory breast carcinoma in one patient provides evidence for the treatment of such carcinoma: A case report. Pathology - Research and Practice. 236. 154006–154006. 3 indexed citations
7.
Lei, Ting, et al.. (2022). Genomic characteristics of two breast malignant phyllodes tumors during pregnancy and lactation identified through whole-exome sequencing. Orphanet Journal of Rare Diseases. 17(1). 382–382. 1 indexed citations
9.
Huang, Xin, Xu Deng, Wenyan Li, et al.. (2019). Internal exposure levels of polycyclic aromatic hydrocarbons in children and adolescents: a systematic review and meta-analysis. Environmental Health and Preventive Medicine. 24(1). 31 indexed citations
10.
Liu, Qin, et al.. (2018). Association of prenatal and childhood environment smoking exposure with puberty timing: a systematic review and meta-analysis. Environmental Health and Preventive Medicine. 23(1). 33–33. 20 indexed citations
11.
Li, Wenyan, Qin Liu, Xu Deng, et al.. (2018). Association of prepubertal obesity with pubertal development in Chinese girls and boys: A longitudinal study. American Journal of Human Biology. 30(6). e23195–e23195. 36 indexed citations
12.
Deng, Xu, et al.. (2017). [Determination of polycyclic aromatic hydrocarbons in girls and association between polycyclic aromatic hydrocarbons exposure and puberty timing].. PubMed. 46(5). 743–748. 1 indexed citations
13.
Hu, Wenwei, Chen Wu, Xiaodong Li, et al.. (2017). Serum IL-33 level is a predictor of progression-free survival after chemotherapy. Oncotarget. 8(21). 35116–35123. 17 indexed citations
14.
Liu, Shudan, Qin Liu, Truls Østbye, et al.. (2017). Levels and risk factors for urinary metabolites of polycyclic aromatic hydrocarbons in children living in Chongqing, China. The Science of The Total Environment. 598. 553–561. 40 indexed citations
15.
Qin, Yifei, et al.. (2017). Analgesic activity of cynaropicrinon on post‑inflammatory irritable bowel syndrome visceral hypersensitivity in a rat model. Experimental and Therapeutic Medicine. 14(5). 4476–4482. 2 indexed citations
16.
Hu, Wenwei, Xiaodong Li, Yan Tan, et al.. (2016). Interleukin-33 Expression does not Correlate with Survival of Gastric Cancer Patients. Pathology & Oncology Research. 23(3). 615–619. 8 indexed citations
17.
Deng, Xu, Jiang Li, Quanxing Liu, et al.. (2016). Lymph node micrometastases are associated with disease recurrence and poor survival for early-stage non-small cell lung cancer patients: a meta-analysis. Journal of Cardiothoracic Surgery. 11(1). 28–28. 21 indexed citations
18.
Deng, Xu, et al.. (2015). Esophageal Cancer with a Synchronous Multiple Carcinoid of the Duodenal Bulb. Indian Journal of Surgery. 77(6). 543–544. 2 indexed citations
19.
20.
Liu, Quanxing, Hong Zheng, Xu Deng, Dong Zhou, & Jigang Dai. (2015). Status of the Parkinson’s disease gene family expression in non-small-cell lung cancer. World Journal of Surgical Oncology. 13(1). 238–238. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026